Invention Application
- Patent Title: FUSION PROTEINS
- Patent Title (中): 融合蛋白
-
Application No.: US11853517Application Date: 2007-09-11
-
Publication No.: US20080064092A1Publication Date: 2008-03-13
- Inventor: Keith FOSTER , John CHADDOCK , Philip MARKS , Patrick STANCOMBE , Lyndsey DUROSE
- Applicant: Keith FOSTER , John CHADDOCK , Philip MARKS , Patrick STANCOMBE , Lyndsey DUROSE
- Applicant Address: GB Salisbury SP4 0JD
- Assignee: SYNTAXIN LTD.
- Current Assignee: SYNTAXIN LTD.
- Current Assignee Address: GB Salisbury SP4 0JD
- Priority: GB0426397.6 20041201
- Main IPC: C07K14/00
- IPC: C07K14/00 ; C12N15/62 ; C12N15/63

Abstract:
The invention provides a single chain, polypeptide fusion protein, comprising: a non-cytotoxic protease, or a fragment thereof, which protease or protease fragment is capable of cleaving a protein of the exocytic fusion apparatus of a target cell; a Targeting Moiety that is capable of binding to a Binding Site on the target cell, which Binding Site is capable of undergoing endocytosis to be incorporated into an endosome within the target cell; a protease cleavage site at which site the fusion protein is cleavable by a protease, wherein the protease cleavage site is located between the non-cytotoxic protease or fragment thereof and the Targeting Moiety; and a translocation domain that is capable of translocating the protease or protease fragment from within an endosome, across the endosomal membrane and into the cytosol of the target cell.
Public/Granted literature
- US08124405B2 Fusion proteins Public/Granted day:2012-02-28
Information query